|
发表于 2015-5-6 05:50:04
|
显示全部楼层
应该不是一回事。
Cytokine-induced killer cells (CIK) are existing cells in human’s body, its responsibility is to search and kill the cancer cells. They are CD3-and CD56-positive, non-major histocompatibility complex (MHC)-restricted, natural killer (NK)-like T lymphocytes, generated ex-vivo by incubation of peripheral blood lymphocytes (PBLs) with anti-CD3 monoclonal antibody, interleukin (IL)-2, IL-1, and interferon gamma (IFN-gamma) and then expanded. When reintroduced back to patients after autologous stem cell transplantation, CIK cells may recognize and kill tumor cells associated with minimal residual disease (MRD). CIK cells may have enhanced cytotoxic activity compared to lymphokine-activated killer (LAK) cells.
The goal of DC-based cancer immunotherapy is to use the cells(DC) to prime specific antitumor immunity through the generation of effector cells(such as T cells) that attack and lyse tumors.
用流式方法检测这些细胞应该是可行的。
|
|